iCardiac Expands Sales and Marketing Team

... Technologies , Inc., a leader in advanced cardiac safety ECG services and automated QT analysis, ... at this exciting transformation point in the cardiac core laboratory industry," said Ms. Boyle. ... for avoiding false positives and negatives in cardiac safety studies." About iCardiac ...

Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update

... Picoplatin Clinical Developments cardiac Safety Study : Announced results from a cardiac safety study of picoplatin in patients with solid ... and Drug Administration (FDA), and evaluated the cardiac safety of picoplatin by determining its effect on ...

iCardiac Processes Volume of Data Equivalent to One Thousand Traditional Thorough QT Studies

... Establishes New Throughput Standard in cardiac Core Lab Industry ... iCardiac Technologies, Inc., a leader in advanced cardiac safety biomarker development and automated QT ... that it has processed a total of 45 million cardiac cycles for agency facing studies in a single ...

Symphony Medical Changes Name to CardioPolymers, Inc.

... on novel biopolymer implant therapies to treat cardiac abnormalities, announced today that it has ... natural biocompatible polymer implants to treat cardiac patients - specifically, congestive heart failure ... to a healthier form that facilitates improved cardiac function and performance. About ...

ERT Appoints New Vice President of Project Management

... will report to the Executive Vice President of cardiac Safety Operations. In this new role, Ms. Miller ... Project Management team works closely with the cardiac Safety and Customer Care teams. Amy Furlong, EVP, cardiac Safety Operations at ERT, said, "With Tammy's ...

Boston Scientific Announces European Approval for Its LATITUDE(R) Patient Management System

... remotely monitors patients with implantable cardiac devices, gathering information on both the device ... 2006, making it the most rapidly adopted remote cardiac device monitoring system in the industry(1)," said Fred Colen, President, Boston Scientific cardiac Rhythm Management. "We expect continued success ...

iZumi Bio and Pierian Merge to Form iPierian to Advance Cellular Reprogramming

... causes of heart disease and on using knowledge of cardiac developmental pathways to devise novel therapeutics for human cardiac disorders. Dr. Douglas Melton is ... of Pediatrics at UCSF, and is an expert in cardiac differentiation. Dr. Bruneau's research focuses ...

iCardiac Selected by Top 10 Pharmaceutical Company

... iCardiac Technologies, Inc., a leader in advanced cardiac safety biomarker development and automated QT ... of advanced methods for evaluating pharmaceutical cardiac safety," said Sasha Latypova, Executive Vice ... to both increase precision of early clinical cardiac safety studies as well as minimize the current ...

OmniComm Systems Announces Acquisition of EDC Business of eResearchTechnology

... worldwide to collect, interpret, and distribute cardiac safety and clinical data, today announced that ... organization. We will continue to expand our core cardiac safety and ePRO business lines." Revenues of ... Inc.) ( http://www.ert.com ) is a provider of cardiac safety and ePRO technology and services to the ...

iCardiac Selected for Multiple Cardiac Safety Studies

... iCardiac Technologies, Inc., a leader in advanced cardiac safety biomarker development and automated QT ... by a medium sized pharmaceutical company for cardiac safety evaluation comprising multiple Thorough QT ... selected iCardiac because of both iCardiac's cardiac safety expertise in relation to complex drug ...

Pixantrone Significantly Increases Complete Remissions, Overall Response Rates, Frequency of Durable Remissions and Progression Free Survival in Patients with Relapsed and Refractory Aggressive Non-Hodgkin's Lymphoma

... is limited by the significant increase in risk of cardiac failure associated with high cumulative doses of ... study arms (18% vs. 13%). Although the grade 3, 4 cardiac disorder was similar among the two treatment ... there was a slightly higher incidence of serious cardiac disorders in patients treated with pixantrone ...

Centocor Ortho Biotech Data to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting

... The use of DOXIL may lead to cardiac toxicity. Myocardial damage may lead to ... of total cumulative dose cardiac toxicity may also occur at lower cumulative doses ... Additional Safety Information cardiac function should be carefully monitored ...

SyntheMed Receives Australian Regulatory Approval for REPEL-CV(R)

... film for the reduction of adhesions following cardiac surgery, has received approval from the ... by Tag Medical Pty Ltd., a distributor of cardiac surgery products. Marc Sportsman, SyntheMed's ... REPEL-CV is FDA approved for use in pediatric cardiac surgery patients and is marketed in the United ...

Amgen Exercises Option for Exclusive License to Cytokinetics' Cardiac Contractility Program That Includes CK-1827452

... worldwide (excluding Japan), to Cytokinetics' cardiac contractility program. The license includes CK-1827452, a novel cardiac myosin activator being developed for the ... to provide for the advancement of this novel cardiac muscle activator into studies that are designed ...

Boston Scientific to Donate Cardiac Rhythm Management Devices to Heartbeat International for Implantation in Needy Patients

... ) today announced that it has agreed to donate cardiac Rhythm Management (CRM) devices, including pacemakers, implantable cardioverter defibrillators and cardiac resynchronization therapy devices to Heartbeat ... said Fred Colen, President, Boston Scientific cardiac Rhythm Management. "We are proud to support the ...

Boston Scientific Announces Company Schedule for Heart Rhythm Society Scientific Sessions

... implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) ... Time) Tuesday, May 12 cardiac Rhythm Management Allied Health Symposium. The ... Hotel, 425 Summer St., Boston. cardiac Rhythm Management Symposium. The Company will ...

ATS Medical Announces Participation in the Annual Meeting of the American Association for Thoracic Surgeons

... ), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced ... relevant products designed to meet the needs of cardiac surgeons and their patients. (Logo: ... which will be hosted by several preeminent cardiac surgeons including Richard Shemin, MD, from UCLA ...

Avoiding False Positives Key Priority in Cardiac Safety Studies

... Companies Recognizing Risks with Traditional cardiac Safety Approaches ... Inc., a leading innovator in advanced cardiac safety biomarkers and automated QT analysis, ... When asked about the key priorities for cardiac safety studies, avoiding false positives was ...

CryoLife Reports Record First Quarter Revenues of $26.7 Million

... in the first quarter of 2008. The increase in cardiac and vascular tissue processing revenues was ... was partially offset by reduced revenues from cardiac tissues primarily from the Company's standard ... of 2008, representing 21 percent of the Company's cardiac tissue processing revenues in the first quarter ...

Symphony Medical Announces First Patient Successfully Treated With Novel Congestive Heart Failure Therapy

... a developer of novel biopolymer therapies to cardiac abnormalities, announced today that its patented ... is performed on patients undergoing a planned cardiac surgery for mitral valve regurgitation or ... to a healthier form that facilitates improved cardiac function and performance. The first ...

The Journal of Cardiac Failure Publishes Results From Celladon Corporation's First-in-Human Phase 1/2 Clinical Trial in Advanced Heart Failure

... by Percutaneous Administration of Gene Therapy in cardiac Disease (CUPID Trial) Demonstrated Safety and ... in the April 2009 issue of the Journal of cardiac Failure . The CUPID clinical trial demonstrated ... has been shown to reverse the disease and restore cardiac function. "Despite important therapeutic ...

iCardiac Applies Advanced Cardiac Safety Biomarkers in Clinical Study for Top Pharmaceutical Company

... Technologies announced today that its advanced cardiac safety biomarkers were used successfully in a ... company to model the effects of disease on cardiac repolarization. The information provided by ... enables drug developers to separate reliably the cardiac effects triggered by experimental drugs. ...

Amorcyte Reports Phase I Results of AMR-001 to Improve Recovery From Severe Heart Attack at ACC Annual Scientific Session

... in perfusion, a trend towards improved cardiac function and the potential to reduce subsequent adverse cardiac events following AMI. The findings were presented ... the risk of recurrent heart attack, other adverse cardiac events and death. The study results showed ...

Heart Disease: An Epidemic For Firefighters

... of suffering sudden death or other significant cardiac events. Firefighters are known to have a three hundred percent increased risk for cardiac disease as compared to other segments of the ... the sudden death of one of his firefighters from cardiac arrest while fighting a house fire. "This ...

Cardiorobotics Announces New CEO, PLSG Executive-in-Residence to Lead Company

... specialist areas, including: minimally-invasive cardiac surgery, electrophysiology, natural orifice and a ... trials and then commercialization for single port cardiac procedures," stated Dr. Straface. Dr. ... technology platform for minimally-invasive cardiac surgery, allowing a wide range of epicardial ...

FDA Approves SyntheMed's REPEL-CV(R) Adhesion Barrier for Use in Pediatric Cardiac Surgery

... REPEL-CV(R) Adhesion Barrier for use in pediatric cardiac surgery patients. REPEL-CV is a bioresorbable ... as the first anti-adhesion product for use in cardiac surgery marks a major milestone for our company," ... Inc. "We now look forward to providing US-based cardiac surgeons with a means of reducing the risks to ...

ChanTest Acquires Applied Cell Sciences

... as H1 histamine receptors, may produce sudden cardiac death by blocking the cardiac HERG ion channel. ChanTest's scientists pioneered ... 'fight-or-flight' reaction is mediated by cardiac GPCR beta-receptors ...

iCardiac Reports Significant Revenue Growth and Profitability

... Inc., a leading innovator in advanced cardiac safety biomakers and automated QT analysis, today ... select iCardiac as a critical provider for their cardiac safety studies because of the company's ... which can both dramatically reduce the cost of cardiac safety studies in addition to reducing the ...

CryoLife Reports Record Annual Revenues of $105.1 Million for FY 2008

... the year ended December 31, 2007. Combined cardiac and vascular tissue processing revenues for the ... was primarily due to a decrease in shipments of cardiac tissues, which management believes is due to the ... effect on hospital budgets. Combined cardiac and vascular tissue processing revenues for the ...

Sopherion Therapeutics, LLC Announces Publication of Phase I/II Myocet(R) (Nonpegylated Liposomal Doxorubicin) Data in Advanced Breast Cancer Patients

... has its own, well recognized, potential for cardiac toxicity. Myocet is a liposomal delivery ... important therapeutic benefits, while diminishing cardiac toxicity," said Ronald H. Goldfarb, Ph.D., ... was designed to determine the recommended dose, cardiac safety and antitumor activity of nonpegylated ...

ERT (eResearchTechnology, Inc.) and Integrium, LLC Form Alliance to Deliver Integrated Cardiac Safety and Ambulatory Blood Pressure Monitoring Services

... today their alliance to provide integrated cardiac Safety and Ambulatory Blood Pressure Monitoring ... to meet the increased demand for centralized cardiac safety and ABPM services during clinical trials. ... and data delivery for primary and secondary cardiac clinical trial endpoints. Integrium will ...

Cordex Pharma Presents 'New Frontiers in Cardiovascular Medicines' on January 29

... patients with heart failure. The risk of sudden cardiac death in heart failure patients is six to nine ... ATPace, for the treatment and diagnosis of cardiac arrhythmias. Cordex expects to initiate a ... and improve excitation-contraction coupling and cardiac pumping efficiency." Dr. Stamler completed ...

NewCardio Joins the Cardiac Safety Research Consortium

... industry in the development of advanced ECG cardiac safety tools SANTA CLARA, Calif., Jan. 22 ... -- NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiac diagnostic and services company, today announced it has become a member of the cardiac Safety Research Consortium (CSRC). The CSRC ...

CryoLife, Inc. Receives Tissue From 100,000th Donor, Marking Industry Milestone

... for transplant. More than 40 percent of the cardiac tissue preserved by CryoLife is implanted into ... of implantable living human tissues for use in cardiac and vascular surgeries throughout the U.S. and ... hemostatic agent, in much of the U.S. for use in cardiac and vascular surgery and in the United Kingdom, ...

ATS Medical Announces Formation of Cryoablation Surgical Advisory Board

... ), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today reported the ... advocates of the surgical treatment of cardiac arrhythmias, including James L. Cox, MD, ATS ... structural heart disease. ATS Medical serves the cardiac surgery community by focusing on two distinct ...

vProtect(TM) Luminal Shield Stabilizes Life-Threatening Plaque

... "Given that there are more than 500,000 sudden cardiac deaths in the US, and more than 300,000 in Europe ... plaques, the culprit in a majority of sudden cardiac deaths." Patients enrolled in SECRITT I have ... Shield represents a logical extension of modern cardiac medicine: "We are very good at opening arteries ...

Cardiogenesis Announces Addition of Raymond W. Cohen to Board of Directors

... therapies to treat heart failure and other cardiac abnormalities. For the decade prior to ... served as Chairman and CEO of publicly traded cardiac Science, Inc . having served in that role during ... with Quinton Cardiology in late 2005. Today cardiac Science is a leading manufacturer of automated ...

Terumo Interventional Systems Launches a Complete Line of Coronary Diagnostic Catheters

... of Interventional Cardiology at Miami Baptist cardiac & Vascular Institute. With a simple ... reduced ... are great tools and make radial cardiac catheterization easier," said Tak Kwan, MD, FACC ... of Medicine, Senior Associate Director of cardiac Catheterization Laboratory and Interventional ...

Frost & Sullivan Presents CorMatrix Cardiovascular Inc. with 2008 Healthcare Innovation Award for the Treatment of Cardiovascular Disease

... ECM Technology(TM) for pericardial closure and cardiac tissue repair. "Frost & Sullivan acknowledges ... and continuous innovation that characterizes the cardiac device market," said Frost & Sullivan industry ... U.S. and has been implanted in more than 9,000 cardiac procedures. About CorMatrix ECM Technology(TM) ...

CorMatrix Announces Pre-Clinical Data Suggesting Next Generation ECM Technology(TM) Can Improve Cardiac Function

... version of their ECM Technology(TM) improved cardiac function. The study tested the hypothesis that ... an extended period showed significant reversal of cardiac damage and improvement in overall function ... U.S. and has been implanted in more than 9,000 cardiac procedures. "We have received a tremendous ...